| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/10/2013 | US8603980 Glutamate receptor antagonists and methods of use |
| 12/10/2013 | US8603979 von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes |
| 12/10/2013 | US8603978 Use of muramyl dipeptide (MDP) for treating inflammation |
| 12/10/2013 | US8603977 Conformationally constrained parathyroid hormone (PTH) analogs |
| 12/10/2013 | US8603976 Methods of enhancing functioning of the large intestine |
| 12/10/2013 | US8603975 Cyclic peptide compounds |
| 12/10/2013 | US8603974 Salmon follitropin hormone analogs |
| 12/10/2013 | US8603973 Skincare composition comprising HSA fusion protein, preparation method and uses thereof |
| 12/10/2013 | US8603972 Extended GLP-1 compounds |
| 12/10/2013 | US8603971 Methods for reducing CD36 expression |
| 12/10/2013 | US8603970 Insulin derivatives having an extremely delayed time-action profile |
| 12/10/2013 | US8603969 Pancreatic polypeptide family motifs and polypeptides comprising the same |
| 12/10/2013 | US8603968 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and their uses |
| 12/10/2013 | US8603967 Carrier peptide fragment and use thereof |
| 12/10/2013 | US8603966 Amino acid-based compounds, their methods of use, and methods of screening |
| 12/10/2013 | US8603965 Pharmaceutical composition for the prophylaxis and treatment of HIV infection and its use |
| 12/10/2013 | US8603781 Prevention of incorporation of non-standard amino acids into protein |
| 12/10/2013 | US8603780 Methods and compositions for enhanced expression and secretion of proteins |
| 12/10/2013 | US8603779 Non-cytotoxic protein conjugates |
| 12/10/2013 | US8603778 Anti-TNF antibodies, compositions, methods and uses |
| 12/10/2013 | US8603560 Milk protein isolate and process for its preparation |
| 12/10/2013 | US8603546 Herbal supplement for increased muscle strength and endurance for athletes |
| 12/10/2013 | US8603541 Viral inactivated platelet extract, use and preparation thereof |
| 12/10/2013 | US8603529 Polynucleotide aptamer-based cross-linked materials and uses thereof |
| 12/10/2013 | US8603525 Multilayer orally disintegrating tablet |
| 12/10/2013 | US8603487 Palmitoylated AB 1-15 in a liposome as a treatment for amyloid associated diseases |
| 12/10/2013 | US8603486 Protein A compositions and methods of use |
| 12/10/2013 | US8603471 Methods and compositions for preventing the onset of type 1 diabetes |
| 12/10/2013 | US8603464 Alkaline phosphatase to reduce weight gain or induce weight loss |
| 12/10/2013 | US8603462 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 12/10/2013 | US8603456 Method of treating hair loss with compositions containing interleukin-1 |
| 12/10/2013 | US8603455 Removal promoters and inhibitor for apoptosis cells in vivo |
| 12/10/2013 | US8603076 Microfabricated nanopore device for sustained release of therapeutic agent |
| 12/10/2013 | CA2589975C Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/10/2013 | CA2570396C Antibacterial peptides and analogues thereof |
| 12/10/2013 | CA2518268C Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone |
| 12/10/2013 | CA2489250C Composition comprising viscous fibers and viscosity-lowering proteins |
| 12/10/2013 | CA2476984C Lactoferrin as an agent for enhancing action of an opioid |
| 12/10/2013 | CA2471947C Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex |
| 12/10/2013 | CA2465314C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 12/10/2013 | CA2453173C Mycobacterial antigens expressed during latency |
| 12/10/2013 | CA2451026C Mycobacterial antigens expressed under low oxygen tension |
| 12/10/2013 | CA2443617C Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 12/10/2013 | CA2436501C Educated nk t cells and their uses in the treatment of immune-related disorders |
| 12/10/2013 | CA2415325C Preventing airway mucus production by administration of egf-r antagonists |
| 12/10/2013 | CA2385528C Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 12/10/2013 | CA2385032C G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 12/05/2013 | WO2013181584A2 Modulation of hepatitis b virus cccdna transcription |
| 12/05/2013 | WO2013181511A1 Sustained delivery of molecules using peptide surfactants and uses thereof |
| 12/05/2013 | WO2013181472A1 Treatment of stress-related disorders |
| 12/05/2013 | WO2013181462A1 Use of amg 900 for the treatment of cancer |
| 12/05/2013 | WO2013181454A1 Plant lectins as carriers of associated drug substances into animal and human cells |
| 12/05/2013 | WO2013181447A1 Methods of treating celiac disease |
| 12/05/2013 | WO2013181446A2 Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of n-acetyl-aspartic acid |
| 12/05/2013 | WO2013181438A2 Compositions and methods for modulating pro-inflammatory immune response |
| 12/05/2013 | WO2013181338A1 Methods for treating and preventing radiation injury using activated protein c polypeptides |
| 12/05/2013 | WO2013181228A1 Dna modifying fusion proteins and methods of use thereof |
| 12/05/2013 | WO2013180799A1 Engineered botulinum neurotoxin |
| 12/05/2013 | WO2013180537A2 Skin-permeating peptide |
| 12/05/2013 | WO2013180316A1 Composition capable of improving stability of bacteriophage lysine proteins |
| 12/05/2013 | WO2013180271A1 Prodrug of fluorine-containing amino acid |
| 12/05/2013 | WO2013180253A1 pH-SENSITIVE CARRIER AND METHOD FOR PRODUCTION THEREOF, pH-SENSITIVE MEDICINE AND pH-SENSITIVE PHARMACEUTICAL COMPOSITION EACH CONTAINING SAID CARRIER, AND CULTURE METHOD USING SAID pH-SENSITIVE MEDICINE OR SAID pH-SENSITIVE PHARMACEUTICAL COMPOSITION |
| 12/05/2013 | WO2013180209A1 Therapeutic agent for glaucoma containing peptide derivative |
| 12/05/2013 | WO2013180011A1 Anti-bacterial peptide and use thereof |
| 12/05/2013 | WO2013179910A1 Agent for preventing and/or treating peripheral neuropathic pain caused by anti-cancer drug |
| 12/05/2013 | WO2013179302A1 Oral anti-inflammatory formulation comprising potentised cytokine |
| 12/05/2013 | WO2013179290A1 Insulin-containing infant formula |
| 12/05/2013 | WO2013179264A2 Use of compounds that selectively modulate astrocytic release of substances through hemichannels of connexins and pannexins, without influencing gap junctions, for the treatment of psychiatric disorders |
| 12/05/2013 | WO2013179258A1 New release system of hydrophobic proteins |
| 12/05/2013 | WO2013179143A2 Sensitization of cancer cells by the removal of soluble tumor necrosis factor receptors |
| 12/05/2013 | WO2013178880A1 Composition for preventing headaches |
| 12/05/2013 | WO2013178788A2 Manufacture of degarelix |
| 12/05/2013 | WO2013178763A1 Methods for treating vestibulotoxicity |
| 12/05/2013 | WO2013178490A1 Pancreatic polypeptide compounds and use |
| 12/05/2013 | WO2013178008A1 Mimetic peptide of erythropoietin, preparation method and uses thereof |
| 12/05/2013 | WO2013177866A1 Use of rana grahami skin repair-promoting polypeptides ah90 and cw49 |
| 12/05/2013 | WO2013177647A1 Culture medium for bacteria of the genus clostridium without components of animal origin, and method for producing a supernatant containing one or more proteases with colagenolytic and gelatinolytic activity |
| 12/05/2013 | WO2013152351A3 Fusion polypeptides and methods of use thereof |
| 12/05/2013 | WO2013102921A4 Hcg - newer treatment modality for type 2 diabetes mellitus (t2dm) |
| 12/05/2013 | WO2007124461A8 Glp-1 compounds |
| 12/05/2013 | US20130324483 Mammalian cell surface antigens; related reagents |
| 12/05/2013 | US20130324482 Compstatin analogs for treatment of rhinosinusitis and nasal polyposis |
| 12/05/2013 | US20130324481 Sustained release eye drop formulations |
| 12/05/2013 | US20130324479 Methods for inducing epithelial cancer cell senescence |
| 12/05/2013 | US20130324475 Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation |
| 12/05/2013 | US20130324473 Coagulating Collagen and Means for Preparing Same |
| 12/05/2013 | US20130324472 Therapeutic method for treating congestive heart failure |
| 12/05/2013 | US20130324471 Treatment |
| 12/05/2013 | US20130324470 Cross-linked gelatin composition comprising a wetting agent |
| 12/05/2013 | US20130324469 Fibrinogen and kidney damage |
| 12/05/2013 | US20130324468 METHODS OF TREATING DISEASES ASSOCIATED WITH PPARy |
| 12/05/2013 | US20130324466 Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Prophylaxis of Heart Failure |
| 12/05/2013 | US20130324463 Use of a dpp-4 inhibitor for modifying food intake and regulating food preference |
| 12/05/2013 | US20130324462 Method of Reducing The Effects of Chemotherapy Using Flagellin Related Polypeptides |
| 12/05/2013 | US20130324461 Methods and compositions for preventing or treating obesity |
| 12/05/2013 | US20130323759 Spinal muscular atrophy diagnostic methods |
| 12/05/2013 | US20130323314 Novel Nanoparticles of Lactoferrin Useful for Preparing a Pharmaceutical Composition Facilitating Easy Delivery of the Drug and a Process for Preparing the Same |
| 12/05/2013 | US20130323311 Collagen-targeted nanoparticles |
| 12/05/2013 | US20130323295 Monomer systems with dispersed silicone-based engineered particles |
| 12/05/2013 | US20130323288 Pharmaceutical formulation for bedwetting and method of use thereof |